Evidence map›Paper›PMID 20397937›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2010

Developing and evaluating comprehensive HIV infection control strategies: issues and challenges.

Victor DeGruttola, Davey M Smith, Susan J Little, Veronica Miller

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Translation of biomedical prevention strategies for HIV: prospects and pitfalls.Journal of acquired immune deficiency syndromes (1999) · 2013
    Review
  9. Review
  10. Review
  11. Review
  12. The HIV Epidemic: High-Income Countries.Cold Spring Harbor perspectives in medicine · 2012
    Review
  13. Article
  14. Modeling interventions to assess HIV epidemic impact in Africa.Journal of acquired immune deficiency syndromes (1999) · 2011
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Victor DeGruttolaDepartment of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. victor@sdac.harvard.edu
Davey M Smith
Susan J Little
Veronica Miller

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
Transmission ProbabilityP01AI074621 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET · 2008 to 2012
$23.1M
Primary Infection Resource Consortium (PIRC)R24AI106039 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LITTLE, SUSAN JANET · 2013 to 2021
$23.1M
UCSD Department of Medicine HIV/AIDS Clinical Trials UnitU01AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 2007 to 2011
$19.3M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 1999 to 2009
$17.8M
A Multi-Site Investigation into the Effect of HIV Clade on Neurocognitive ImpairmR01MH083552 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2008 to 2012
$3.3M
Methods to Advance the HIV Prevention Research AgendaR37AI051164 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI DEGRUTTOLA, VICTOR GERARD · 2012 to 2019
$3.3M
Methods for Long-Term Follow-Up of HIV-Infected PatientsR01AI051164 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI DEGRUTTOLA, VICTOR GERARD · 2002 to 2011
$3.0M
HIV-1 Adaptation in the Central Nervous SystemR01NS051132 · NINDS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WONG, JOSEPH K · 2005 to 2009
$1.8M
Detection and Characterization of HIV-1 Intraclade Dual InfectionR21AI077304 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI SMITH, DAVID MITCHELL · 2008 to 2009
$381k
NIAID NIH HHS AI074621NIAID NIH HHS AI077304NIAID NIH HHS AI36214NIAID NIH HHS AI-51164-01NIAID NIH HHS AI69432NIAID NIH HHS AI74621NIAID NIH HHS P01 AI074621NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI051164NIAID NIH HHS R21 AI077304NIAID NIH HHS R24 AI106039NIAID NIH HHS R37 AI051164NIAID NIH HHS U01 AI069432NIAID NIH HHS UM1 AI069432NIDA NIH HHS DA012065NIDA NIH HHS P01 DA012065NIMH NIH HHS MH083552NIMH NIH HHS MH62512NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH083552NINDS NIH HHS NS051132NINDS NIH HHS R01 NS051132
6 · The paper itself

Abstract

As described elsewhere in this supplement, development of effective methods for prevention of human immunodeficiency virus (HIV) infection has proven to be more challenging than development of effective treatment for the disease. New strategies to control the HIV epidemic are urgently needed; this urgency creates interest in investigation of the possibility of using antiretroviral treatment in combination with other modalities to control the epidemic. This article summarizes current knowledge concerning prevention modalities in the context of the drivers of the HIV epidemic in specific communities, describes challenges in investigating test-and-treat strategies, and proposes research directions for addressing these challenges to investigate the impact of prevention strategies on mitigation of epidemics.

Indexed as

Communicable Disease ControlHealth Services ResearchHIV InfectionsHumans

Identifiers

PMID20397937
PMCPMC2913596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.